Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 199 results found. Search for [ bharat biotech's covaxin ]

Results 160 to 180 of 199
BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 23, 2020
This inoculation adds to Bharat Biotech's portfolio of vaccines currently being developed by it and are in several stages of clinical development, comprising COVAXIN- which is India's first indigenous vaccine against coronavirus


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
New Delhi, September 13, 2020
Covaxin, the vaccine candidate from Bharat Biotech has proved effective in non-human primates in Phase I clinical trials in India. Covaxin, developed by the ICMR and Bharat Biotech International, is being tested at 12 institutes across the country. The results of the first phase of testing are encouraging. Watch the video for more.


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


BusinessToday.In
August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal


BusinessToday.In
August 22, 2020
Bharat Biotech has received nod to conduct the Phase I and II clinical trial of its COVID-19 vaccine 'Covaxin' through intradermal route, which is just under the skin


PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year


BusinessToday.In
August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19


BusinessToday.In
August 19, 2020
Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials


BusinessToday.In
New Delhi, August 19, 2020
COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...


BusinessToday.In
August 18, 2020
Oxford vaccine news update: The government had formed a coronavirus vaccine expert committee that held discussions on the distribution plans of the vaccine. The trials would be conducted across 10 centres at first


BusinessToday.In
August 4, 2020
Coronavirus vaccine update: Jeevan Rekha Hospital was among the 12 facilities selected by the ICMR to conduct human trials of Covaxin


BusinessToday.In
August 2, 2020
The investment in July was lower than Rs 24,053 crore pumped in June as FPIs maintained a \"cautious stance\" while investing in India as coronavirus cases continued to surge


BusinessToday.In
July 25, 2020
Coronavirus vaccine news: Serum Institute of India will start trials of the Oxford University-AstraZeneca COVID-19 vaccine by the end of August. Up to 5,000 Indian volunteers would be included in the tests


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
New Delhi, July 22, 2020
Covaxin, an experimental novel coronavirus vaccine developed by Hyderabad-based Bharat Biotech, has begun human trials at New Delhi's All India Institute of Medical Sciences this week. AIIMS-New Delhi is one the 12 sites chosen by the Indian Council of Medical Research, which is a collaborator on the Covaxin novel coronavirus vaccine project, for conducting human trials. How much time will this vaccine take, how many trials will take place and where. Watch the video to know more.Govt warns 59 Chinese apps of serious action if found operating despite ban


BusinessToday.In
July 19, 2020
Coronavirus vaccine news update: Only 100 participants out of the 375 volunteers would be picked for the first and second phases. The rest would participate in trials at other sites


BusinessToday.In
New Delhi, July 19, 2020
Hyderabad-based Bharat Biotech's candidate vaccine for coronavirus got the nod for human trials earlier this month. The first trial has started on 375 people. The company's Chairman & MD Dr Krishna Ella speaks to India Today TV about the progress made so far and when Indians could expect it in the market, if all went well.Also Read: COVID-19 impact: Indian spices rise in demand for immunity properties, exports up 34% in June


PAGES 9 OF 10  678910